Welcome to the Utah Chapter of the American College of Cardiology
|
Ed Miner, MD, FACC Utah, Chapter President ACC Governor, Utah |
Please join your cardiology colleagues at the ACC Rockies Chapter Meeting in Park City, Utah for updates on ACC affairs, the potential new CV Board, and clinical topics such as Genetic and Sports EP, plus a discussion on the growing role of obesity medications in heart failure, and the first-ever Cardiology State-of-the-State report. There will be many opportunities for networking, as well!. For more information and to register, please visit:
ACC Rockies Chapter Meeting 2025
ACC Live Courses For a listing of all ACC Live Courses please visit: https://www.acc.org/education-and-meetings/meetings |
Latest in Cardiology from ACC.org
- Eagle’s Eye View: Top 2025 ACC ContentIn this episode, Dr. Eagle looks back at 2025 and explores some of the significant developments that show how the College is responding to changes in the way we evaluate, manage, and follow patients with various types of cardiovascular disorders.
- SURPASS-CVOT: Is Tirzepatide Superior to Dulaglutide in Patients With T2D and ASCVD?Tirzepatide was noninferior to dulaglutide among patients with type 2 diabetes (T2D) and atherosclerotic cardiovascular disease (ASCVD), with respect to the primary composite outcome of cardiovascular death, myocardial infarction (MI) or stroke...
- Reducing Saturated Fat May Reduce Mortality, NFMI, Stroke in High-Risk IndividualsAmong individuals with an elevated baseline cardiovascular risk, reducing the intake of saturated fatty acid (SFA) was associated with a lower risk of mortality, nonfatal myocardial infarction (NFMI) and stroke over five years, according to a systematic review published Dec. 16 in Annals of Internal Medicine.
- The OPTION Trial: Percutaneous Left Atrial Appendage Occlusion Devices Rise as an Option Post AblationCatheter ablation has become an effective treatment strategy for patients with AF. In 2009, the ThermoCool AF (NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation) trial results showed that ablation to treat...
- ACCEL Lite: Should There Be a Reappraisal of Surgical Threshold in Patients with AA Dilation?In this interview, Glenn A. Hirsch MD, MHS, FACC and Milind Y. Desai, MD, MBA, FACC discuss “Should There Be a Reappraisal of Surgical Threshold in Patients with Ascending Aortic Dilation?".